Cargando…
REinforcement learning to improve non-adherence for diabetes treatments by Optimising Response and Customising Engagement (REINFORCE): study protocol of a pragmatic randomised trial
INTRODUCTION: Achieving optimal diabetes control requires several daily self-management behaviours, especially adherence to medication. Evidence supports the use of text messages to support adherence, but there remains much opportunity to improve their effectiveness. One key limitation is that messa...
Autores principales: | Lauffenburger, Julie C, Yom-Tov, Elad, Keller, Punam A, McDonnell, Marie E, Bessette, Lily G, Fontanet, Constance P, Sears, Ellen S, Kim, Erin, Hanken, Kaitlin, Buckley, J Joseph, Barlev, Renee A, Haff, Nancy, Choudhry, Niteesh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647547/ https://www.ncbi.nlm.nih.gov/pubmed/34862289 http://dx.doi.org/10.1136/bmjopen-2021-052091 |
Ejemplares similares
-
Preferences for mHealth Technology and Text Messaging Communication in Patients With Type 2 Diabetes: Qualitative Interview Study
por: Lauffenburger, Julie C, et al.
Publicado: (2021) -
Randomised controlled trial targeting habit formation to improve medication adherence to daily oral medications in patients with gout
por: Fontanet, Constance P, et al.
Publicado: (2021) -
Overcoming Decisional Gaps in High-Risk Prescribing by Junior Physicians Using Simulation-Based Training: Protocol for a Randomized Controlled Trial
por: Lauffenburger, Julie C, et al.
Publicado: (2022) -
Clinicians’ and Patients’ Perspectives on Hypertension Care in a Racially and Ethnically Diverse Population in Primary Care
por: Lauffenburger, Julie C., et al.
Publicado: (2023) -
Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol
por: Lauffenburger, Julie C., et al.
Publicado: (2021)